Technology Updates

As part of a new series of updates on technology, and to complement on Clinuvel's public news flow, Clinuvel has initiated a regular bulletin to provide its followers worldwide with the latest advances on relevant issues, such as environmental factors, skin and related biochemical issues.

These discussions aim to increase the understanding of the science and technology behind Clinuvel’s progress in pharmaceutical development. Where the depth of information becomes too profound we have tried to summarise concepts into easier terms.

Technology Update I - The physiological "UV tanning response", original thoughts on UV and pigmentation

Technology Update II - Afamelanotide as an adjunct to phototherapy

Technology Update III - Stem cells and repigmentation in vitiligo

Read Related Blog Posts

Image

Lung, heart, mouth, nose, throat ...

In what has become something of a tradition in recent years, yet another country has used the new year to... Read more...

Image

Talking off the label – part th...

Allergan’s lawsuit filed against the FDA presents a relatively novel case in addressing the requirements of... Read more...

Image

Talking off the label - part two...

Following on from last week’s conversation, I left off with the issues surrounding the off-label... Read more...

Watch Related Videos

Part Four - The impact of Eryt...

Mikey's quality of life, like all patients with Erythropoietic Protoporphyria (EPP), is severely affected. Severe pain f... Watch now

Understanding Vitiligo - Cause...

Vitiligo is a common pigmentary disorder in which the pigment producing cells of the skin (melanocytes) are absent or do... Watch now

Part Three - Burning in shadow...

This is the third webcast in a series featuring Mikey, an Australian man with Erythropoietic Protoporphyria (EPP). You c... Watch now

JoomlaXTC K2 Content Wall - Copyright 2010 Monev Software LLC

SCENESSE Spotlight

SCENESSE® as a repigmentation therapy

Clinuvel is currently conducting two clinical trials to evaluate the efficacy of SCENESSE® as a combination therapy with narrowband ultraviolet B (NB-UVB) phototherapy compared to NB-UVB alone. The goal of these trials is to determine whether SCENESSE® will re... Read more

JoomlaXTC K2 Content Wall - Copyright 2010 Monev Software LLC